Sightful Invest
  • Business
  • Investing
  • Politics
  • Stock
Top Posts
Comey to be arraigned in federal court after...
Comey pleads not guilty in court after indictment...
Houthi rebels test US ceasefire with deadly strike...
Kushner joins Witkoff for Gaza ceasefire talks as...
Cuomo rips Mamdani’s freebie ‘fantasy,’ says AOC proved...
White House escalates shutdown consequences as Democrats show...
Moderate Dem undercuts Jeffries on ObamaCare compromise as...
MIKE DAVIS: The Supreme Court betrayed again —...
Senate Democrats defy White House warnings, again block...
Greta Thunberg slammed for using image of starved...
  • Business
  • Investing
  • Politics
  • Stock

Sightful Invest

Politics

HHS Secretary Robert F Kennedy Jr to face Senate panel after CDC turmoil

by admin September 4, 2025
September 4, 2025
HHS Secretary Robert F Kennedy Jr to face Senate panel after CDC turmoil

Health and Human Services Secretary Robert F. Kennedy Jr. is set to testify on Capitol Hill on Thursday, a week after turmoil engulfed the Centers for Disease Control and Prevention (CDC).

Lawmakers on the Senate Finance Committee, which has jurisdiction over the HHS, will hear from Kennedy on President Donald Trump’s healthcare agenda, dubbed by the secretary as the Make America Healthy Again movement.

While the committee does not directly oversee the CDC, the recent firing of former CDC Director Susan Monarez, the wave of high-level officials departing and other moves at the agency taken under Kennedy’s tenure are expected to dominate the line of questioning from both Republicans and Democratic lawmakers on the panel.

Senate Majority Leader John Thune, who is a member of the panel, told reporters that Kennedy would face ‘hard questions’ from committee members, particularly over frustrations over Monarez, who was confirmed by the Senate less than a month before her ouster.

‘He’s gotta take responsibility… we confirm these people,’ the South Dakota Republican said. ‘We go through a lot of work to get them confirmed. And they’re in office a month?’

Speculation has swirled over the reason behind Monarez’s firing given her differing stance on vaccines compared to Kennedy, who spent much of his presidential campaign and tenure as secretary going after the efficacy and safety of vaccination, particularly those for COVID-19.

Sen. Bill Cassidy, R-La., who chairs the Senate health committee and was the deciding vote that propelled Kennedy to a role in the Trump administration, is also set to question the secretary.

Last week, he demanded that the federal government’s vaccine advisory panel, which was filled with Kennedy’s handpicked replacements after he recently booted the original panel members, postpone its scheduled meeting in September until ‘significant oversight’ was carried out by his committee, and charged that any recommendations made by the advisory panel should be rejected until then.

Cassidy told Fox News Digital that he was working on just what the oversight measures would look like and expected to announce his plans soon. In the meantime, he noted that he was supportive of Kennedy and Trump’s commitment to ‘radical transparency,’ but noted that his main concerns were about children’s health.  

‘It isn’t about R versus D. It isn’t about, you know, internecine fights within the Republican Party. It is about children and grandchildren, and will they die or be at risk of dying from vaccine-preventable disease,’ Cassidy said. ‘Now we’ve got to get to the truth of this.’

He also argued that members of the Advisory Committee on Immunization Practices are supposed to receive materials to review before making vaccine recommendations and decisions, but questioned where the information would be coming from in the wake of several senior members of the CDC making their exit after Monarez’s firing.

‘We’ve got to have some sort of radical transparency into what scientific justification is being used for that,’ he said. ‘Is it a political appointee? Well, to say a political appointee is making scientific recommendations. Who’s a political appointee? I mean, are they a doctor, a PhD, or are they a political appointee? Our concern is they might just be political appointees, but we’re going to find that out.’

Sen. Steve Daines, R-Mont., another member of the Senate Finance Committee, told Fox News Digital that his line of questioning would focus on the abortion drug Mifepristone and its safety, but added that it was ‘fair’ for lawmakers to have debate over Kennedy’s leadership of the CDC and HHS.

‘It’s typical for any secretary that comes up, but I’m sure many of these issues that have been raised are related to some concerns. These questions are going to be asked, and I’m grateful that the Secretary will be there to explain what he sees going on and the path forward,’ he said.

Meanwhile, Kennedy defended his moves at the CDC in a Wall Street Journal opinion piece on Tuesday and contended that ‘President Trump has asked me to restore that trust and return the CDC to its core mission.’

He wrote that steps have already been taken to ‘eliminate conflicts of interest and bureaucratic complacency’ at the agency, and that leaders who ‘resisted reform’ had already been replaced.

‘Most CDC rank-and-file staff are honest public servants,’ Kennedy said. ‘Under this renewed mission, they can do their jobs as scientists without bowing to politics. The agency will again become the world authority on infectious-disease policy.’

‘First, the CDC must restore public trust — and that restoration has begun,’ he continued. ‘It won’t stop until America’s public-health institutions again serve the people with transparency, honesty and integrity.’

Fox News Digital reached out to the HHS for comment but did not hear back immediately. 

This post appeared first on FOX NEWS

previous post
Macquarie Electro Jet Silver Extraction Recovery
next post
Federal judges anonymously criticize Supreme Court for overturning decisions with emergency rulings

You may also like

Trump’s new American doctrine means peace through strength...

June 30, 2025

VP Kamala Harris could name one of these...

July 31, 2024

Trump or Harris? Israelis discuss presidential choice as...

September 7, 2024

White House pressed on Biden refusing to speak...

December 21, 2024

‘No means of escape’: Sudanese rebels create kill...

September 9, 2025

With 26 days until voting starts, ‘election season’...

August 11, 2024

How Kamala Harris’ failed 2024 presidential run mirrors...

November 7, 2024

Rashida Tlaib hit with House censure threat, accused...

September 3, 2025

American father of Hamas hostage Itay Chen pushes...

October 7, 2024

Who was Yahya Sinwar? The Israeli prisoner turned...

October 18, 2024

Recent Posts

  • Comey to be arraigned in federal court after being indicted for alleged false statements, obstruction
  • Comey pleads not guilty in court after indictment on alleged false statements, obstruction
  • Houthi rebels test US ceasefire with deadly strike on cargo ship
  • Kushner joins Witkoff for Gaza ceasefire talks as Trump pushes peace plan: ‘Cautiously optimistic’
  • Cuomo rips Mamdani’s freebie ‘fantasy,’ says AOC proved socialism fails after killing NYC Amazon deal

    Sign up for our newsletter to receive the latest insights, updates, and exclusive content straight to your inbox! Whether it's industry news, expert advice, or inspiring stories, we bring you valuable information that you won't find anywhere else. Stay connected with us!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Categories

    • Business (936)
    • Investing (3,147)
    • Politics (3,845)
    • Stock (4)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: sightfulinvest.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 Sightful Invest. All Rights Reserved.